comparemela.com

Page 3 - Myeloma Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Schinke on the Safety Profile of Talquetamab in Relapsed/Refractory Myeloma

Dr Schinke on the Safety Profile of Talquetamab in Relapsed/Refractory Myeloma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

University of arkansasMyeloma centerMedical sciences

Jason Browning Hired as General Counsel at CARTI (Movers & Shakers)

He was previously an attorney at Wright Lindsey Jennings.

United statesUnited states air force hospitalLittle rockUniversity of arkansasHarold deanMegan boswellSheheryar shahStephen broughtonJackie hancock jrWright lindsey jenningsJason browningRoberth hopkins jrKatie halsellKristin koenigsfestNational foundation for infectious diseasesSciences of little rock

Dr Schinke on the Rationale for the MonumenTAL-1 Trial in Multiple Myeloma

Carolina D. Schinke, MD, discusses the rationale for conducting the phase 1/2 MonumenTAL-1 trial in patients with multiple myeloma.

Myeloma centerUniversity of arkansasMedical sciencesOnclive tvMultiple myeloma

Talquetamab Produces Durable Responses in Relapsed/Refractory Multiple Myeloma

Carolina D. Schinke, MD, discusses key efficacy findings from the MonumenTAL-1 trial, adverse effects to be aware of with talquetamab, and what the findings from this trial reveal about the potential future for talquetamab and other bispecific antibodies in patients with multiple myeloma.

Myeloma centerUniversity of arkansasSciences in little rockMedical sciencesLittle rockMultiple myelomaCarolinad schinkeMonumental 1 trialUniversity of arkansas for medical sciences

Dr Schinke on Talquetamab in Multiple Myeloma

Carolina D. Schinke, MD, discusses updated findings from the phase 1/2 MonumenTAL-1 trial in patients with multiple myeloma.

Myeloma centerUniversity of arkansasMedical sciences

vimarsana © 2020. All Rights Reserved.